In this context, mutations in the following genes of the shelterin protein complex (POT1, TPP1, TERF2IP, and TINF2) have also been associated with familial melanoma, glioma, and chronic lymphocytic leukemia (CLL) [28]. This evidence concerns the gene TERF2IP and B-cell chronic lymphocytic leukemia.